Home
About
About Us
News
Certificate
Our team
Manufacturing | r&d
Manufacturing | r&d
Scientific Insights
Products
oncology-product
Order Now
Careers
Contact Us
Login
Scientific Insights
Scientific Insights
Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease
May 15, 2025
Scientific Insights
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
May 15, 2025
Scientific Insights
Safety of Lorlatinib in patients with Unresectable advanced ALK-Positive Non-Small-Cell Lung Cancer
May 15, 2025
Scientific Insights
Status of Sickle Cell Disease Among Tharu Population In Banke District of Nepal
May 15, 2025
Scientific Insights
Sequential Afatinib & Osimertinib in Asia Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M
May 15, 2025
Scientific Insights
Osimertinib in EGFR Mutated Non-Small Cell Lung Cancer
May 15, 2025
Search
Must Read
क्यान्सर विरुद्धको औषधि उत्पादन गर्ने नेपालको पहिलो कम्पनी– टिजिग फर्मा विदेशमा पनि औषधिको माग
March 14, 2025
क्यान्सर रोगविरूद्धको औषधि उत्पादन अब नेपालमै
March 14, 2025
नेपालमा उत्पादित क्यान्सरविरुद्धको औषधिको माग विदेशमा
March 14, 2025
नेपालमै उत्पादित क्यान्सरको औषधि बजारमा
March 14, 2025
Distribution of first-ever Nepal-manufactured anti-cancer drug starts
March 14, 2025
Categories
Certificate
News
Scientific Insights
